1. Home
  2. NPCE vs BCYC Comparison

NPCE vs BCYC Comparison

Compare NPCE & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$15.48

Market Cap

432.3M

Sector

Health Care

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$5.14

Market Cap

360.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPCE
BCYC
Founded
1997
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
432.3M
360.7M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
NPCE
BCYC
Price
$15.48
$5.14
Analyst Decision
Strong Buy
Buy
Analyst Count
6
10
Target Price
$18.33
$13.90
AVG Volume (30 Days)
165.9K
584.2K
Earning Date
05-12-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
29.03
N/A
EPS
N/A
N/A
Revenue
$99,986,000.00
N/A
Revenue This Year
$0.90
N/A
Revenue Next Year
$24.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.13
N/A
52 Week Low
$7.56
$4.24
52 Week High
$18.97
$9.55

Technical Indicators

Market Signals
Indicator
NPCE
BCYC
Relative Strength Index (RSI) 62.07 54.14
Support Level $15.25 $5.03
Resistance Level $15.71 $5.90
Average True Range (ATR) 0.67 0.24
MACD 0.22 0.09
Stochastic Oscillator 91.26 81.08

Price Performance

Historical Comparison
NPCE
BCYC

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: